Skip to main content
. 2024 Nov 5;10(1):101668. doi: 10.1016/j.adro.2024.101668

Table 1.

Patient, tumor, and treatment variables for patients who received 26 Gy in 5 fractions ± boost between March and August 2020

Variable No. patients (%)
(a) Patient

Age, y at diagnosis
<40 1 1
40-49 7 5
50-59 33 24
60-69 50 37
70-79 39 29
80+ 5 4

(b) Tumor

Breast cancer laterality
Left 64 47
Right 71 53
Histology type
Ductal 105 78
Lobular 11 8
Mixed 8 6
Other 11 8
Tumor stage
Tis 2 2
T1 91 67
T2 41 30
T3 0 0
T4 1 1
No. of positive nodes
pN0 117 87
pN1 (mi) 12 9
pN1a 5 3
pN2 1 1
Estrogen receptor status
Positive 126 93
Negative 9 7
Her2 receptor status
Positive 12 9
Negative 123 91
Tumor grade
Grade 1 27 20
Grade 2 73 54
Grade 3 35 26
Lymphovascular invasion
Absent 97 72
Present 38 28

(c) Treatment

Type of surgery
Mastectomy 5 4
Breast-conserving 130 96
Axillary staging
Sentinel node biopsy 133 98
Axillary clearance 1 1
No axillary surgery 1 1
RT
Whole breast only 97 72
Whole breast + sequential boost
10.68 Gy/4 f 25 19
12 Gy/4 f 1 1
13.35 Gy/5 f 2 2
16 Gy/8 f 5 3
Chest wall 5 3
Deep inspiration breath hold
Yes 21 16
No 114 84

All women 135 100

Abbreviations: f = fraction; RT = radiation therapy.